期刊文献+

下呼吸道感染的抗菌药物应用分析 被引量:2

Application of antibiotics for treatment of lower respiratory tract infections
原文传递
导出
摘要 目的调查和评价下呼吸道感染抗菌药物的使用情况,以指导临床合理用药。方法回顾性分析某医院2008年1月-2010年12月405例下呼吸道感染患者的抗菌药物治疗情况。结果头孢菌素类、喹诺酮类、大环内酯类是下呼吸感染使用最多的3大类抗菌药物;抗菌药物单用的101例占24.94%,二联应用280例占69.14%,三联应用24例占5.93%;405例患者中有158例送痰标本做细菌培养,送检率为39.01%,其中只有38例阳性,阳性率为24.40%。结论该医院下呼吸道感染的治疗,以经验性抗感染治疗为主,病原学检查重视不够,应加强管理。 OBJECTIVE To monitor and evaluate the application of antibiotics for the lower respiratory tract infections,so as to guide the reasonable clinical medication.METHODS A retrospective investigation was conducted for the application of antibiotics for the treatment of 405 patients with lower respiratory tract infections from Jan 2008 to Dec 2010.RESULTS The main types of antibiotics which were frequently used were cephalosporins,quinolones,and macrolides.There were 101(24.94%) cases of single-joint administration,280(69.14%) cases of the two-drug combination,and 24(5.93%)cases of the three-drug combination.There were 158 of 405 patients whose sputum specimens were submitted for the bacterial culture with the submission rate of 39.01%,among which 38 cases were cultured positive with the positive rate of 24.40%.CONCLUSION The empirical anti-infection treatment is the main therapy for the lower respiratory tract infections,and great attention should be paid to the etiology examination.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第21期4876-4878,共3页 Chinese Journal of Nosocomiology
基金 2011年度广州市黄埔区政府资助项目[(埔)0742]
关键词 下呼吸道 感染 抗菌药物 合理使用 Lower respiratory tract Infection Antibiotics Reasonable application
  • 相关文献

参考文献5

二级参考文献23

共引文献54

同被引文献27

  • 1中华人民共和国卫生部,国家中医药管理局,解放军总后勤部卫生部.关于施行《抗菌药物临床应用指导原则》的通知[J].中华医学杂志,2004,84(22):1857-1857. 被引量:109
  • 2Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2007, 44(Suppl 2): S27-S72.
  • 3Mccrory DC, Brown C, Gelfand SE, et al. Management of acute exacerbations of COPD: a summary and appraisal of published evidence[J]. Chest, 2001, 119(4): 1190-1209.
  • 4Snow V, Lascher S, Mottur-Pilson C. The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part1[J]. Chest, 2001, 119(4): 1185-1189.
  • 5Bierman KW, Morrow LE, Holweger JD, et al. Compliance with ATS-IDSA guideline recommendations for empiric antibiotic therapy in pneumonia[J]. Chest, 2010, 138(4): 856.
  • 6Polso AK,Lassiter JL,Nagel JL.Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review[J].J Clin Pharm Ther,2014,39(6):584-608.
  • 7Akaike H,Miyashita N,Kubo M,et al.In vitro activities of 11antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients:results from a multicenter surveillance study[J].Jpn J Infect Dis,2012,65(6):535-538.
  • 8Yoshida K,Okimoto N,Kishimoto M,et al.Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis[J].Infect Chemother,2011,17(5):678-685.
  • 9Kakinuma Y,Maeda Y,Mason C,et al.Molecular characterisation of the quinolone resistance-determining regions(QRDR)including gyrA,gyrB,parC and parE genes in Streptococcus pneumoniae[J].Br J Biomed Sci,2012,69(3):123-125.
  • 10Ubukata K.Mechanisms of beta-lactam and quinolone resistance in Haemophilus influenzae[J].Nihon Rinsho,2012,70(2):247-250.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部